Patent · US Active

Vaccines for malaria

US8999347B2 · kind B2 · utility

2Cited by

0References

15Claims

0Family size

Assignee

GLAXOSMITHKLINE BIOLOGICALS SA · BE

Inventors

Joseph Cohen · Brussels, BE
Martine Marchand · Rixensart, BE

Key dates

Filing date	Dec 22, 2008
Grant date	Apr 7, 2015
Priority date	—
Expiry date	Aug 14, 2030

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a novel lipoprotein particle, methods for preparing and purifying the same, its use in medicine, particularly in the prevention of malarial infections, compositions/vaccines containing the particle or antibodies against the protein particle such as monoclonal or polyclonal antibodies and use of the same, particularly in therapy. Furthermore, particles with the specific ratio can be prepared by employing yeast, Saccharomyces cerevisiae or Pichia pastoris. In particular it relates to an immunogenic protein particle comprising the following monomers:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.